What is prompting this biotech stock (TNXP) higher in the pre-market session?
TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company focused on the discovery, licensing, acquisition, and development of small molecules and biologics to treat and prevent diseases in humans and prevent suffering. TONIX PHARMACEUTICALS stock surged 26.49% to $1.170 in the pre-market session today. Get the hottest stocks to trade every day before […]
